Related Experiment Video
Updated: Jul 20, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
[Characteristics of myocardial revascularization in aged patients with ischemic heart disease]
A Iu Titkov1, K L Kovlov, Iu S Titkov
1St.-Petersburg Institute of Bioregulation and Gerontology of North-Western Branch, Russian Academy of Medical Sciences, 3, Dynamo Prospect, St. Petersburg, 197110.
Insights
Choosing the right treatment for elderly patients with ischemic heart disease (IHD) is challenging. Advanced therapies like coronary angioplasty and CABG have significantly reduced cardiovascular disease mortality.
Area of Science:
- Cardiology
- Vascular Surgery
Context:
- Cardiovascular diseases are a leading cause of global mortality and disability.
- Atherosclerosis is a primary contributor to morbidity in industrialized nations.
- Optimal treatment selection for elderly patients with ischemic heart disease (IHD) presents a significant clinical challenge.
Purpose:
- To explore the challenges in selecting surgical or interventional treatments for elderly patients with IHD.
- To highlight the impact of advanced therapies on cardiovascular disease outcomes.
Summary:
- Elderly patients with ischemic heart disease (IHD) require careful consideration for treatment.
- High-technology interventions, including coronary angioplasty and coronary artery bypass grafting (CABG), have proven effective.
- These advanced methods have contributed to a 30% reduction in cardiovascular disease mortality in the US and Europe.
Impact:
- Reduced mortality from cardiovascular diseases in elderly populations.
- Improved management strategies for atherosclerosis and IHD.
- Advancements in interventional cardiology and cardiac surgery techniques.
Abstract:
One of the main difficulties in cardiology is how to correctly choose the tactickof surgical or interventional treatment in elderly patients with IHD. It is widely known that cardiovascular diseases are the main cause of mortality and invalidization all over the world. Atherosclerosis, by WHO data, takes the leading place in morbidity of industrial countries population. In USA and Europe it has become possible to reduce mortality from cardiovascular diseases by 30% due to active application in clinical practice of hi-tech methods of IHD treatment in elderly patients-coronary angioplasty and CABG.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Myocarditis I: Introduction
Myocarditis III: Medical Management